Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
vaccine
3:34
Innovations in viral vector development
Nathalie Clement
• 27 Jan 2022
2:01
Medical applications of polyhydroxyalkanoates
Ipsita Roy
• 11 Nov 2021
2:04
Learnings from the COVID-19 pandemic for the advanced therapies sector
Miguel Forte
• 5 Oct 2021
1:32
The potential of oncolytic adenoviral vectors
Margarita Romanenko
• 13 May 2021
2:45
What can the field learn from the COVID-19 pandemic?
Amy DuRoss
• 8 Apr 2021
3:10
The lasting impact of COVID-19 on the CGT sector
Stephen Ward
• 14 Apr 2021
2:05
Novel oncolytic Ad6 vectors for cancer therapy
Margarita Romanenko
• 13 May 2021
2:07
Exosome-based mRNA vaccines against SARS-CoV-2
Linda Marban
• 19 May 2021
1:46
Regulating gene therapies: what can be learned from COVID-19?
Nicole Faust
• 9 Apr 2021
4:18
Building partnerships between patients and industry
Durhane Wong-Rieger
• 6 Apr 2021
1:56
Educating patients in cell and gene therapies
Durhane Wong-Rieger
• 6 Apr 2021
2:12
The future impact of COVID-19 on the gene therapy sector
Nicole Faust
• 9 Apr 2021
